Your browser doesn't support javascript.
loading
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.
Hegenbart, Ute; Bochtler, Tilmann; Benner, Axel; Becker, Natalia; Kimmich, Christoph; Kristen, Arnt V; Beimler, Jörg; Hund, Ernst; Zorn, Markus; Freiberger, Anja; Gawlik, Marianne; Goldschmidt, Hartmut; Hose, Dirk; Jauch, Anna; Ho, Anthony D; Schönland, Stefan O.
Afiliación
  • Hegenbart U; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany ute.hegenbart@med.uni-heidelberg.de.
  • Bochtler T; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany.
  • Benner A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Germany.
  • Becker N; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Kimmich C; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Kristen AV; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany.
  • Beimler J; Division of Cardiology, University of Heidelberg, Germany.
  • Hund E; Division of Nephrology, University of Heidelberg, Germany.
  • Zorn M; Department of Neurology, University of Heidelberg, Germany.
  • Freiberger A; Division of Clinical Chemistry, University of Heidelberg, Germany.
  • Gawlik M; Coordination Center for Clinical Trials, KKS, Heidelberg, Germany.
  • Goldschmidt H; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany.
  • Hose D; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany.
  • Jauch A; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany.
  • Ho AD; Institute of Human Genetics, University Heidelberg, Germany.
  • Schönland SO; Department of Internal Medicine, Division of Hematology/Oncology, University of Heidelberg, Germany.
Haematologica ; 102(8): 1424-1431, 2017 08.
Article en En | MEDLINE | ID: mdl-28522573
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2017 Tipo del documento: Article País de afiliación: Alemania